Suppr超能文献

哮喘症状效用指数:成人哮喘患者的信度、效度、反应度和最小重要差异。

Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients.

机构信息

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Allergy Clin Immunol. 2012 Nov;130(5):1078-84. doi: 10.1016/j.jaci.2012.07.058. Epub 2012 Sep 29.

Abstract

BACKGROUND

The evaluation of asthma symptoms is a core outcome measure in asthma clinical research. The Asthma Symptom Utility Index (ASUI) was developed to assess the frequency and severity of asthma symptoms. The psychometric properties of the ASUI are not well characterized, and a minimal important difference (MID) is not established.

OBJECTIVES

We assessed the reliability, validity, and responsiveness to change of the ASUI in a population of adult asthmatic patients. We also sought to determine the MID for the ASUI.

METHODS

Adult asthmatic patients (n = 1648) from 2 previously completed multicenter randomized trials were included. Demographic information, spirometric results, ASUI scores, and other asthma questionnaire scores were obtained at baseline and during follow-up visits. Participants also kept a daily asthma diary.

RESULTS

The internal consistency reliability of the ASUI was 0.74 (Cronbach α). Test-retest reliability was 0.76 (intraclass correlation). Construct validity was demonstrated by significant correlations between ASUI scores and Asthma Control Questionnaire scores (Spearman correlation r = -0.79; 95% CI, -0.85 to -0.75; P < .001) and Mini Asthma Quality of Life Questionnaire scores (r = 0.59; 95% CI, 0.51-0.61; P < .001). Responsiveness to change was demonstrated, with significant differences between mean changes in ASUI scores across groups of participants differing by 10% in percent predicted FEV(1) (P < .001) and by 0.5 points in Asthma Control Questionnaire scores (P < .001). Anchor-based and statistical methods support an MID for the ASUI of 0.09 points.

CONCLUSIONS

The ASUI is reliable, valid, and responsive to changes in asthma control over time. The MID of the ASUI (range of scores, 0-1) is 0.09.

摘要

背景

哮喘症状的评估是哮喘临床研究中的核心结局指标。哮喘症状效用指数(ASUI)是为评估哮喘症状的频率和严重程度而开发的。ASUI 的心理测量特性尚未得到很好的描述,也没有确定最小有意义差异(MID)。

目的

我们评估了 ASUI 在成年哮喘患者人群中的可靠性、有效性和对变化的反应能力。我们还试图确定 ASUI 的 MID。

方法

纳入了来自 2 项先前完成的多中心随机试验的成年哮喘患者(n=1648)。在基线和随访就诊时获得了人口统计学信息、肺量计结果、ASUI 评分和其他哮喘问卷评分。参与者还每天记录哮喘日记。

结果

ASUI 的内部一致性可靠性为 0.74(Cronbach α)。测试-重测可靠性为 0.76(组内相关)。ASUI 评分与哮喘控制问卷评分(Spearman 相关 r=-0.79;95%CI,-0.85 至-0.75;P<.001)和 Mini 哮喘生活质量问卷评分(r=0.59;95%CI,0.51-0.61;P<.001)之间存在显著相关性,证明了结构效度。变化反应能力得到了证明,在预测 FEV1 百分比变化 10%的参与者组之间的 ASUI 评分均值变化之间存在显著差异(P<.001),在哮喘控制问卷评分上存在 0.5 分的差异(P<.001)。基于锚定和统计方法支持 ASUI 的 MID 为 0.09 分。

结论

ASUI 具有可靠性、有效性和对哮喘控制随时间变化的反应能力。ASUI 的 MID(评分范围,0-1)为 0.09。

相似文献

2
Psychometric Properties of the Asthma Symptom Index in Patients with Severe Asthma.哮喘症状指数在重度哮喘患者中的心理测量特性。
J Allergy Clin Immunol Pract. 2021 Jan;9(1):400-409.e1. doi: 10.1016/j.jaip.2020.08.019. Epub 2020 Aug 24.
3
Validation and psychometric properties of the Asthma Control Questionnaire among children.儿童哮喘控制问卷的验证和心理测量特性。
J Allergy Clin Immunol. 2014 Jan;133(1):91-7.e1-6. doi: 10.1016/j.jaci.2013.06.029. Epub 2013 Aug 6.

引用本文的文献

本文引用的文献

1
Asthma outcomes: symptoms.哮喘结局:症状。
J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S124-35. doi: 10.1016/j.jaci.2011.12.981.
3
The minimally important difference of the Asthma Control Test.哮喘控制测试的最小重要差异。
J Allergy Clin Immunol. 2009 Oct;124(4):719-23.e1. doi: 10.1016/j.jaci.2009.06.053. Epub 2009 Sep 19.
8
Predicting episodes of poor asthma control in treated patients with asthma.预测接受治疗的哮喘患者哮喘控制不佳的发作情况。
J Allergy Clin Immunol. 2006 Dec;118(6):1226-33. doi: 10.1016/j.jaci.2006.09.006. Epub 2006 Oct 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验